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The three major outer membrane proteins (OMP)1 of Neisseria gonorrhoeae, Pro-
teins 1, II and III (PI, PII and PIII), have been extensively studied (1, 2), and all
have been cloned and characterized (3-6) . PIII, first describedby McDade andJohn-
ston (7), is constitutively expressed and antigenically invariable . Antibodies to PIII
are able to block complement-dependent killing of the gonococcus by human sera
(8-10) . Furthermore, PIII is closely associated with PI trimers, whichmakes it difficult
to purify PI without PIII contamination (7, 11-14) .
PIII was recently cloned by our laboratory and it was found to have significant
homology to theCOOH-terminal portionof enterobacterialOmpA proteins (3, 4) .
Other investigators have been able to produce OmpA- strains of Escherichia colt
(15-17), and we speculated that PIII minus gonococci could also be produced . A
gonococcal strain that does not express PIII or produces an altered PIII proteinwould
allow investigators to further elucidate the function of PIII, including its role in PI
conformation, function, and membrane insertion . The viability and virulence of
PIII- strains could be tested and the necessity of PIII for pathogenesis could be ex-
amined . Moreover, gonococcal proteins could be purified without PIII contamina-
tion, and therefore, the induction of anti-PIII blocking antibodies by immunizing
preparations of gonococcal proteins could be eliminated .
We are interested in the use of purified PI as a gonococcal vaccine because it has
moderate antigenic variability (18, 19) and antibodies toward PI exhibit bactericidal
and opsonic activity against thegonococcus (20-23) . Theinevitable presence of min-
imal PIII contamination in any PI preparation (11, 12, 14) makes it difficult to avoid
anti-PIII antibody induction when PI is used as an immunogen . In a previous PI
vaccine trial (24), delipidated gonococcal membrane blebs consisting of PI and a
small amount of PIII (<10%) were injected into human volunteers with a previous
history of gonococcal infections . Sera from these volunteers before immunization
had antigonococcal bactericidal and opsonic activity, which decreased after immu-
nization . This is thought to be due to the production of PIII antibodies, which, as
stated, block complement-dependent killing ofgonococci byhuman sera (8-10) . The
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vacinees' sera are currently being analyzed to confirm this. We have recently pub-
lished studies describing the antibody response to PI inserted into liposomes (25-27).
A minor account of PIII antibodies was induced by these preparations, but the sera
still exhibited significant antigonococcal bactericidal and opsonic activity. Nevertheless,
it would be advantageous to purify PI without PIII contamination ifPi is to be used
as a gonococcal vaccine.
This study describes the engineering of a PHI genetic construct by inserting a
fla gene into a cloned PIII gene. This construct was used to transform gonococci
and to replace the wild-type PHI gene by homologous recombination in order to
disrupt PHI production by insertional inactivation. This procedure has been per-
formed in the gonococcus and reported for the IgA protease gene (28) and the recA
gene (29). Once obtained, these transformants were phenotypically and genotypi-
cally characterized, especially for changes in PIII expression.
Materials and Methods
Organisms.
￿
Organisms used were gonococcal strains F62, MS11, Pgh 3-2 (kindly provided
by Dr. Charles Brinton, University ofPittsburgh, Pittsburgh, PA) and UUl (kindly provided
by Dr. Zell McGee, University of Utah, Salt Lake City, Utah) and E. coli strain DH5.
Protein III Gene Construct.
￿
The cloning and sequencing of PIII was previously described
by Gotschlich et al. (3, 4). The PIII Xgtll clone 33 was treated with Eco RI to excise the
PIII insert. The insert was ligated into Eco RI-cut pMOB45 (30), and tetracycline-resistant,
chloramphenicol-sensitive transformants were selected and isolated. A particular isolate was
designated pMOB45/33-2 and was used for further constructions. The lla gene is contained
on a 2.2-kb Barn HI fragment ofplasmid pFA3 (31); the plasmid was purified (32) from E. coli
and this fragment was isolated by restriction enzyme digestion, agarose gel electrophoresis,
and electroelution ofthe restriction enzyme fragment. Approximately 2.5 ug of pMOB45/33-2
was digested with Xba I. The unique PIII Xba I site is located at base pair 601, two-thirds
into the open reading frame (ORF) of the PHI gene (Fig. 1). Approximately 1 gg of the
purified ala Bam HI fragment was added to Xba I-treated pMOB45/33-2 and the 5' over-
hanging ends left by the restriction enzyme digestions were filled using the Klenow fragment
of DNA polymerase to obtain blunt ends. The fragments were ligated with T4 DNA ligase
and transformed into competent cells of E. coli strain DH5.
Four colonies were selected that grew on medium containing tetracycline and carbenicillin,
and plasmids were isolated from these isolates, respectively designated A-D. Restriction map-
ping with Eco RI digestion indicated plasmids A, C, and D gave rise to the expected frag-
ments. Further restriction mapping using Pst I and Pvu I gave rise to identical patterns for
plasmids A and C but different ones from plasmid D, indicating that plasmid D contained
the /31a gene in the opposite orientation than that ofplasmids A and C. We were able to con-
clude from these patterns that the ,Bla insert is in the same direction as the PHI gene in plasmid
D but is in the reverse direction in plasmid A and C (Fig. 1). Plasmids C and D were isolated
in large quantities (32) and then further purified by CsCl equilibrium density gradient cen-
trifugation. Aliquots were methylated using Hae III methylase according to the protocol recom-
mended by the vendor (New England Biolabs Inc., Beverly, MA). This step was performed
in order to protect the DNA from one gonococcal restriction enzyme, Ngo II, which is an
isoschizomer of Hae III (33, 34). The plasmids were then treated with Eco RI to release
the modified gonococcal DNA fragment and then used for transformation.
Transformation.
￿
Transformations were carried out as follows. Competent piliated gono-
cocci of strain F62 were grown for 16-18 h on gonoccal agar (35) in 6% C02 incubator at
37°C and then resuspended in 1.5% Proteose Peptone No. 3 (Difco Laboratories, Detroit,
MI) broth with 30 mM Hepes, pH 7 .2, 10 MM MgC12, 1% isovitalex (GC-Hepes). The
resuspended organisms were diluted to a concentration of 5 x 107 CFU/ml (OD6W = 0.05).
2 Rg of either plasmid C or D, Hae III methylated and cut with Eco kI, were added to 1
ml of the diluted organisms and incubated statically at 37°C. After 1 h, 3 ml of GC-HepesWETZLER ET AL.
￿
2201
was added and the tubes with the organisms were rotated at 30 rpm for 5-6 h at 37°C. Con-
trol tubes were treated identically, but no DNA was added. Various dilutions ofthe organisms
incubated with the DNA (+DNA) and organisms without DNA (control) were spread on
GC agar (35), overlapping a concentration gradient of ampicillin. This gradient was estab-
lished by concentrically spreading 50 IAI of a 1 mg/ml dilution of ampicillin to the middle
two-thirds of each agar plate. After 48 h the plates were examined and healthy, transparent,
piliated colonies that appeared at the edge ofthe ampicillin gradient on plates that were inoc-
ulated with + DNA organisms were selected and propagated on GC agar containing 3 p,g/ml
of ampicillin. Such colonies did not appear on the control plates. The isolates that grew on
the ampicillin plates were then tested with nitrocefin disks (BBL Microbiology Systems, Cock-
eysville, MD) to detect lla activity, and colonies that tested positive were further investigated.
Transformations were also performed using gonococcal strains Pgh 3-2 and UUl, in a similar
manner as above, using total chromosomal DNA or electrophoretically isolated restriction
fragments of chromosomal DNA from transformants obtained from the above experiment.
Chromosomal DNA was obtained using the method of Nakamura et al. (36).
SDS-PAGE and Western Blot.
￿
Similar amounts of whole cell lysates of various strains of
gonococci were studied by SDS-PAGE using a variation of Laemmli's method (37) as previ-
ously described (12). Lysates were made with or without 2-ME to demonstrate that PIII is
reduction modifiable (12). Western blots were performed as described by Towbin et al. (38),
reacted with PIII affinity-purified rabbit sera, and probed with alkaline phosphatase-con-
jugated goat anti-rabbit antiserum (Tago, Inc., Burlingame, CA) (39).
DNAHybridization.
￿
DNA hybridization analyses were performed according to the methods
reviewed by Meinkoth and Wahl (40) and originally described by Southern (41). Probes in-
cluded the Eco RI/Cla I fragment from PIII clone 33, which does not include the known
repetitive sequence of the gonococcus (4), and the Bam HI fragment from plasmid pFA3
(31), which contains the (31a gene.
Whole Organism Absorptions.
￿
Transformants and their parent strains were tested for their
ability to absorb affinity-purified PIII polyclonal rabbit antisera. 0.1 ml of organisms were
diluted in GC-Hepes to obtain an OD6oo equal to 0.6 (5 x 108 CFU) and serially diluted
twofold in V-bottomed microtiter plates. Sera that were to be absorbed were diluted to one-
half the dilution that would give an ELISA reading equivalent to 1 .0. 0.1 ml of diluted sera
was added to the wells, which contained 0.1 ml of diluted organisms, and the plates were
then incubated at 37°C for 2 h. After 2 h, the plates were centrifuged at 2,000 rpm and 0.1 ml
from each well was carefully transferred to an ELISA plate sensitized with 2 hg/ml of PIII.
The ELISA plates were incubated overnight and the remainder of the procedure was per-
formed as a normal ELISA (26). Results were analyzed by comparing readings of sera ab-
sorbed with the organisms to readings of unabsorbed sera.
Phenotypic Characterization ofTransformants.
￿
Antibiotic sensitivity ofvarious strains was de-
termined by the disc diffusion method at the Clinical Microbiology Laboratory of Memorial
Sloan Kettering Hospital, New York, NY. Growth curves were done by inoculating GC-Hepes
with 5 x 10' CFU nonpiliated organisms and measuring OD6oo of each inoculum hourly
until the end of exponential growth. The ability of PI to function as a porin in artificial lipid
bilayers was analyzed as previously described (42) using isolated PI (26). Testing the sensi-
tivity of organisms to killing by cathepsin G was performed as previously described (43) by
Dr. William Shafer (Emory University, Atlanta, GA). To test the competence of the mutant
organisms, transformations were performed as above using chromosomal DNA from
streptomycin-resistant gonococcal strain MS11, and streptomycin-resistant transformants were
detected on gonococcal agar plates containing 1 mg/ml streptomycin.
Results
Gonococci lacking PIII in their outer membrane were obtained by marker rescue.
Our procedure entailed transferring a cloned PIII gene to a plasmid vector and then
inserting a gene encoding Ola into the ORF of the PIII gene. We transformed gono-
cocci with this insertionally inactivated PIII gene construct and isolated organisms
that produced (31a and were penicillin resistant. Variations of this approach using2202
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FIGURE 1 .
￿
Construction of PIII/Ola gene.
01a, 0-lactamase, ORF, open reading
frame;pMOB45/C, plasmidC; pMOB45/
D, plasmid D .
other gonococcal proteins have been reported previously (28, 29). The PIII clone
33 contains a single Xba I site at base pair 601 and because this site is located ap-
proximately two-thirds into the ORF of PIII (Fig. 1) it is possible to disrupt the
translation ofPHI by inserting a (Ola gene marker at that site . For these reasons we
decided to use aplasmid vector that lacked Xba I sites and a01a gene, pMOB45 (30) .
We were able to isolate one colony ofa (01a producing, ampicillin-resistant gono-
coccuswhen piliated F62 gonococci was transformed with Hae III-methylated, Eco
RI-treated pMOB45/33-2/D (plasmid D) . The P111/01a insert in this plasmid has
the Ola gene oriented in the same direction as the PIII gene (Fig. 1) . The isolate
obtained was further propagated on ampicillin containing GC agar and was desig-
nated 2D. Strain 2D lacked a reduction-modifiable protein as seen on SDS-PAGE
(Fig. 2) but other protein bands were equivalent . A Western blot of an identical gel
(Fig . 3) probed with affinity-purified polyclonal PIII antisera demonstrated that whole
cell lysates of 2D exhibited no PIII reactivity, including any truncated version of
PIII or a P111/01a fusion protein . Furthermore, when the mutants were grown in
liquid culture there was no evidence that any version of PIII is excreted into the
culture supernatant (data not shown) . We concluded that this isolate had no im-
munologically discernable fragments of PHI or P111/01a fusion proteins .
FIGURE 2 .
￿
SDS-PAGE of F62 and 2D whole cell lysates . (-)
Without2-ME,(+) with 2-ME . Molecular weight standards were
human transferrin (80,000), catalase (60,000), ovalbumin (45,000),
carbonic anhydrase (30,000), soybean trypsin inhibitor (21,500)
and cytochrome c (15,000) .WETZLER ET AL .
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FIGURE 3.
￿
Western blot of F62 and2D whole cell lysates probed with affinity-
purified PIII polyclonal antisera . (+) With 2-ME ; (-) without 2-ME .
The original phenotype of the isolate was piliated and transparent, but because
the strain was propagated nonpiliated organisms were obtained. Furthermore, the
PIII/Ola mutation was stable when the mutant was passed on plates that did not
contain ampicillin ; O1a reactivity continued to be demonstrable by nitrocefin disks .
There were no gross phenotypic differences between the mutant and wild-type or-
ganism (Table I), but thenonpliliated colonies ofthemutant appeared to be slightly
less cohesive and more fluid as compared with the wild-type . Growth curves of 2D
versus F62 (Fig. 4) demonstrated that 2D growth was slightly less than F62 growth .
PI isolated from 2D, in the absence of PIII, acts exactly the same in a lipid bilayer
as PI from the parent strain; it demonstrates the same voltage-gated porin activity.
CathepsinG, aPMNserine esterase with anti-PIII proteolytic activity, can kill gono-
cocci, even when its proteolytic activity is inhibited (43). There was no difference
in killing by cathepsinG ofPHI containing gonococci and strain 2D (personal com-
munication, Dr.W Shafer, Emory University, Atlanta, GA) . Therefore, the ability
of cathepsin-G to kill gonococci is not related to PHI proteolysis.
The fact that 2D had increased resistance to ampicillin and no longer produced
demonstrable PIII implied that the cloned PHI sequence in plasmid D had been
reintroduced alongwith the Ola gene into the gonococcal chromosomes by homolo-
gous recombination . To confirm this, F62 and2D chromosomalDNA digested with
various restriction enzymes were analyzed using the method of Southern (41) . The
hybridizations were performed using F62 and 2D DNA digested with Eco RI and
Cla I (Fig. 5) . The F62 digests reacted with the PIII probe, revealing a 6.7-kb Eco
RI fragment and a 3.5-kb Cla I fragment, but did not react with the fla probe.
Colony morphology
Growth
Effect of anti-P111 antibody
PIII antibody absorption
CathepsinG killing
Porin activity
Competence
Antibiotic sensitivity
TABLE I
Phenotypic Characterization : 2D vs . F62
Minimal difference
Slightly decreased
No effect on killing by immune sera
2D unable to absorb PHI antibody
No difference
No difference
No difference
Ampicillin resistant (3 Ag/ml)2204
￿
N. GONORRHOEAE LACKING OUTER MEMBRANE PROTEIN III
0.700
0.600+
0.500+
0 0 0 .400
0 0 .300
0.200+
0.100
0.000
0 1 2 3 4 5 6 7 8 9 10
HOURS
FIGURE 4 .
￿
F62 and 2D growth curves
in GC-Hepes medium .
FIGURE 5 . Southern blot hy-
bridization ofF62 and2D chro-
mosomal DNA digested with
Eco RI (E) and Cla I (C).
Probed with (A) [32P]dCTP-
labeled PIII gene, base pairs
0-900 (lacking known repetitive
sequence), and (B) [32p]dCTP-
labeled Sla Barn HI fragment
from pFA3 .
The2D digests reacted similarly with either probe, revealing a 8.9-kb Eco RI frag-
ment and a 5.7-kb Cla I fragment . The reactive 2D fragments were 2 .2 kb larger
than thereactive F62 fragments . 2 .2 kb is the size of the Bam HI fragment ofpFA3
containing the (3la gene, which was inserted into the PIII gene . This verifies that
homologous recombination did occur between the PIII/Ola construct and the
gonococcal chromosomal PIII gene .
2D chromosomalDNA was able to transform competent gonococcal strains F62,
Pgh 3-2 andUU1.AWestern blot ofwhole cell lysates ofPgh 3-2 andUUl transfor-
mants probed with affinity-purified polyclonal PIII antisera can be seen in Fig. 6 .
The frequency of homologous transformation ofF62 was 21ogshigher than heterol-
ogous transformation ofUU1 or Pgh 3-2 (10-3 vs . 10"5, respectively). Furthermore,
FIGURE 6 .
￿
Western Blot of Pgh 3-2 and UUl, wild-type (wt), and
PIII transformant (x) . Probed as in Fig. 3 .WETZLER ET AL.
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the 5.7-kb 2D Cla I fragment, mentioned above, was isolated by agarose gel elec-
trophoresis ofCla I-digested 2D DNAand electroelution ofthe appropriate gel piece.
TheDNA thus retrievedwas able totransform gonococcal strain F62. We also found
that 2D was equally competent as F62 when transformed with chromosomal DNA
from streptomycin resistantstrain MS11; thefrequency oftransformation was2-3 x
10-Z for both 21) and F62.
Discussion
Asthis studydemonstrates, wehave been ableto producestable,viable gonococcal
mutants that lack one ofits major OMP, PIII, in its outer membrane. Even though
this was done by insertional inactivation within the ORF, no immunologically dis-
cernable PIII was produced by the mutant strains. Intact PIII in the gonococci or
in outer membrane blebs is resistant to proteolytic enzymes (44), but once PIII is
purified it is readily attacked by proteases (14). Most likely, the transformants were
producing a shortened PIII protein or a PIII/Ola fusion protein and it is probable
that these alterations prevented insertion ofPIII into the outer membrane permit-
ting exposure to gonococcal endogenous proteases. This is the most likely explana-
tion why a truncated PIII protein or a PIII/ala fusion protein was not detected.
We were able to insert aeila gene into the chromosomal PIII gene by homologous
recombinationasdemonstrated by Southern blotting (Fig. 5). The first transforma-
tionusingaPIII/Ola construct isolatedfrom plasmid D (Fig. 1)propagated in E. coli
andHae III methylated was ableto transformcompetent gonococci, but inefficiently.
Once2D chromosomal DNAor specific 2D DNAfragments containing the PIII/Ola
gene were used, the frequency of transformation increased up to 10-3. We used
Hae III methylated DNA to tranform gonococci because other investigators have
demonstrated that gonococcal transformation with foreign DNAis extremely difficult,
probably because ofgonococcal restriction enzymes, and accordingly, theefficiency
oftransformation can be improved by Hae III methylating theDNAused fortrans-
formation (33, 34).
Gonococcal PIII has significant homology to enterobacterial OmpA (4). E. coli
mutants that lack OmpA are viable but have significant differences from wild-type
E. coli (45). Alterations of OmpA expression cause the organism to be sensitive to
EI7TA anddetergent. Moreover, OmpAmutations and deletions affect E. coli bacte-
riophage sensitivity (16, 17). We created stable PIII- N. gonorrhoeae that are viable
and have minimal changes in colony morphotype and bacterial growth, similar to
OmpA- E. coli. OmpA is necessary for mating pair formation in E. coli (46-49),
and the effect of PHI deletion on gonococcal conjugation is in the process ofbeing
evaluated.
Minimal phenotypic changes were observed between 2D and its parent strain,
F62 (Table 1). The PIII transformation that this strain underwent is stable and does
not requirethe presence ofantibiotics. There is aminordecrease in growth in liquid
culture (Fig. 4). Gram stain and colony morphology ofthe two strains were almost
identical. Additionally, the lack ofPIII in the gonococcal outer membrane does not
affet DNA uptake andcompetence. Purified PIfrom strain 2D retains similarporin
activity as purified PI from wild-type strainscontaining PIII. These resultsdemon-
strate that PI porin function is not affected by the absence ofPIII. We are currently
examining P111- strains in various functional models, e.g., bactericidal assays, in-2206
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vasion assays, and these results will be reported in the future. Preliminary results
(personal communication, Dr. P Rice, Boston University Medical Center, Boston,
MA) demonstate that anti-PIII blocking antibodies decreases complement depen-
dent killing ofwild-type organisms but do not affect complement-dependent killing
of the PIII- transformants.
As mentioned, PI is apromising gonococcal vaccinecandidate, but a complicating
factor in its use is the inveitable presence of PIII in PI preparations. We have used
PI in liposomes to producebactericidal andopsonic antibodies (25-27) butourprepa-
rations still induced some PIII antibodies, even though titers were not high enough
to abolish bactericidal and opsonic activity. PHI antibodies have the potential to
block complement killing of gonococci (8-10), and therefore, even small amounts
of PIII in a gonococcal vaccine preparation can have adverse effects. The results
of the PI/gonococcal bleb vaccine trial performed by Arminjon et al. (24) demon-
strate this point. When delipidated gonococcal membrane blebs consisting ofPI and
small amounts of PHI were injected into volunteers with a previous history of
gonococcal infections, the antigonococcal bactericidal and opsonic activity of their
sera decreased after immunization. We now have organisms that lack PHI and we
have isolated PI from these strains without PHI contamination. We are testing the
immunogenicity of liposome preparations using this PI. In addition to enabling us
to eliminate PIII from purified PI preparations, there is the potential to purify any
other gonococcal membrane protein without PHI contamination.
Summary
Protein III (PIII) is a highly conserved, antigenically stable gonococcal outer mem-
braneprotein that is closely associated with themajoroutermembrane protein, protein
I (PI). We have previously reported the cloning of the PIII gene. This gene was in-
serted into the Eco RI site of therunawayplasmid pMOB45. Thef3-lactamase (Sla)
Bam HI restriction fragment from the gonococcal plasmid pFA3 was inserted at the
Xba I site in the PHI gene. The plasmid construct was Hae III methylated and the
PIII/Ola insert was excised with Eco RI and used to transform gonococcal strain
F62. One lla+, ampicillin-resistant transformant was isolated and designated 2D.
A Western blot of 2D whole cell lysate was probed with affinity-purified polyclonal
PHI antisera. No PIII reactivity wasdetected. Southern blot analysis was performed
on F62 and 2D chromosomalDNA that were cut with Eco RI or Cla I. A PHI DNA
probe hybridized with fragments 2.2 kb larger in strain 2D than strain F62. This
corresponds to the size of the f31a insert. A Ola-specific probe hybridized with the
same 2D restriction fragments as above, but did not react with any F62 fragments,
confirming that homologous recombinationhad occurred. Therewere minimalpheno-
typic changes between 2D and its parent strain, F62. Chromosomal DNA from 2D
was able to transform gonococcal strains F62, UU1, and Pgh 3-2, rendering these
PIII-. 2D and other PIII- transformants can now be used to study the role of PIII
in gonococcal physiology, metabolism, membrane structure, and pathogenesis.
Moreover, we now have organisms from which we can purify gonococcal proteins
without PIII contamination .
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